Based on the experience at a private practice. The adoption process and roles may vary by practice.
Deciding to adopt a biosimilar
Establish a knowledge base
Consulting peer-reviewed journals, conference updates, industry publications, and key opinion leaders
Evaluate the information
Meeting with the product’s pharmaceutical representative
Ensure a consensus
Considering perspectives from stakeholders and opinion leaders
Implementing a biosimilar
Identify eligible patients
Determining which patients may be appropriate for a biosimilar prescription
Choose an adoption approach
Making a plan for future adoptions
Monitoring biosimilar use and experience
Facilitate system updates
Tracking biosimilar inventory
Record relevant learnings
Assessing the benefits of biosimilar adoption
Develop patient-specific tools
Creating guidelines for future biosimilar adoptions
Need more information on biosimilars? We’re here.
Organon does not guarantee that your use of this information will help you achieve your biosimilars goals. This educational resource was prepared in consultation with, and with the permission of, a private practice that had successfully implemented a biosimilar within its organization. The adoption process and roles may vary by institution.
Decide
Implement
Monitor